Search research articles
Contact Us
Filters
Showing results (31-40 of 101) with videos related to
Page
of 11
Sort By:
Proteomics
|
May 16, 2003
Proteome analysis of the purine stimulon from Lactococcus lactis
Natascha H Beyer, Peter Roepstorff, Karin Hammer, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
February 1, 1992
[Computerized diagnostic interpretation of quantitative x-ray diffraction analysis of urinary calculi]
G Rebentisch, W D Pusinelli, J Muche, et al.
Zeitschrift Fur Urologie Und Nephrologie
|
November 1, 1986
[Accelerating factors in the progression of chronic renal failure]
L Lachhein, R Kielstein, E M Rohmann, et al.
Pharmacology
|
May 1, 1997
Studies on pyrazinoylguanidine. 6. Prevention of cataracts in STZ-diabetic rats
M H Follansbee, K H Beyer, E S Vesell
Annals of Hematology
|
May 1, 1992
The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine
T Liersch, J H Beyer, G Krieger, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 12, 1984
[Effect of metoprolol on the elimination kinetics of ethanol]
V Dittmann, O Pribilla, H Beyer, et al.
Pharmacology
|
March 1, 1996
Studies on pyrazinoylguanidine. 2. Comparative drug and dose effects on glucose and lipid metabolism in streptozotocin-induced diabetic rats
Y I A-Rahim, K H Beyer, E S Vesell
Pharmacology
|
March 1, 1996
Studies on pyrazinoylguanidine. 1. Characterization of metabolic effects in diabetic rats
Y I A-Rahim, K H Beyer, E S Vesell
Pharmacology
|
August 6, 1998
Pyrazinoylguanidine in end-stage renal disease: a prospective, placebo-controlled pilot study
N Ahsan, Z Korsunsky, K H Beyer, et al.
Pharmacology
|
October 1, 1996
Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes
Y I A-Rahim, K H Beyer, E S Vesell
Page
of 11
Search research articles
Search
Showing results (31-40 of 101) with videos related to
Sort By:
Page
of 11
Proteomics
|
May 16, 2003
Proteome analysis of the purine stimulon from Lactococcus lactis
Natascha H Beyer, Peter Roepstorff, Karin Hammer, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
February 1, 1992
[Computerized diagnostic interpretation of quantitative x-ray diffraction analysis of urinary calculi]
G Rebentisch, W D Pusinelli, J Muche, et al.
Zeitschrift Fur Urologie Und Nephrologie
|
November 1, 1986
[Accelerating factors in the progression of chronic renal failure]
L Lachhein, R Kielstein, E M Rohmann, et al.
Pharmacology
|
May 1, 1997
Studies on pyrazinoylguanidine. 6. Prevention of cataracts in STZ-diabetic rats
M H Follansbee, K H Beyer, E S Vesell
Annals of Hematology
|
May 1, 1992
The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine
T Liersch, J H Beyer, G Krieger, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 12, 1984
[Effect of metoprolol on the elimination kinetics of ethanol]
V Dittmann, O Pribilla, H Beyer, et al.
Pharmacology
|
March 1, 1996
Studies on pyrazinoylguanidine. 2. Comparative drug and dose effects on glucose and lipid metabolism in streptozotocin-induced diabetic rats
Y I A-Rahim, K H Beyer, E S Vesell
Pharmacology
|
March 1, 1996
Studies on pyrazinoylguanidine. 1. Characterization of metabolic effects in diabetic rats
Y I A-Rahim, K H Beyer, E S Vesell
Pharmacology
|
August 6, 1998
Pyrazinoylguanidine in end-stage renal disease: a prospective, placebo-controlled pilot study
N Ahsan, Z Korsunsky, K H Beyer, et al.
Pharmacology
|
October 1, 1996
Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes
Y I A-Rahim, K H Beyer, E S Vesell
Page
of 11